PD-1 and PD-L1 binding agents
US12351633B2 · kind B2 · utility
0Cited by
14References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2022 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Jun 23, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to agents that bind PD-1 or PD-L1 and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the PD-1 or PD-L1 binding agents and their use in the treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.